Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,191,388
+$2,744,874 QoQ
Shares Held
27,937
+78.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#210
of 593 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $1,134,714,630 across 20 Diagnostics & Research names. GH ranks #16 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
535,154 | $268,304,808 | |
| 2 | DHR |
Danaher Corp /De/
|
872,810 | $166,252,848 | |
| 3 | WAT |
Waters Corp /De/
|
332,814 | $124,818,562 | |
| 4 | LH |
Labcorp Holdings Inc.
|
434,693 | $121,714,040 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
195,579 | $103,576,682 | |
| 6 | ILMN |
Illumina, Inc.
|
456,654 | $80,293,472 | |
| 7 | QGEN |
Qiagen N.V.
|
1,670,207 | $65,305,093 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
79,090 | $41,636,139 |
All Filings in GH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,191,388 | 27,937 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,446,514 | 15,660 | Shares | Defined | 2026-05-13 | |
| 2025-09-30 | $1,679,337 | 26,878 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,418,714 | 27,262 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $983,974 | 23,098 | Shares | Defined | 2025-05-08 | |
| 2020-09-30 | $9,804,447 | 87,712 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,992,351 | 86,187 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $5,113,372 | 73,468 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||